Literature DB >> 10688826

Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin.

L Alberio1, O Safa, K J Clemetson, C T Esmon, G L Dale.   

Abstract

Factor V (FV) present in platelet alpha-granules has a significant but incompletely understood role in hemostasis. This report demonstrates that a fraction of platelets express very high levels of surface-bound, alpha-granule FV on simultaneous activation with 2 agonists, thrombin and convulxin, an activator of the collagen receptor glycoprotein VI. This subpopulation of activated platelets represents 30.7% +/- 4.7% of the total population and is referred to as convulxin and thrombin-induced-FV (COAT-FV) platelets. COAT-FV platelets are also observed on activation with thrombin plus collagen types I, V, or VI, but not with type III. No single agonist examined was able to produce COAT-FV platelets, although ionophore A23187 in conjunction with either thrombin or convulxin did generate this population. COAT-FV platelets bound annexin-V, indicating exposure of aminophospholipids and were enriched in young platelets as identified by the binding of thiazole orange. The functional significance of COAT-FV platelets was investigated by demonstrating that factor Xa preferentially bound to COAT-FV platelets, that COAT-FV platelets had more FV activity than either thrombin or A23187-activated platelets, and that COAT-FV platelets were capable of generating more prothrombinase activity than any other physiologic agonist examined. Microparticle production by dual stimulation with thrombin and convulxin was less than that observed with A23187, indicating that microparticles were not responsible for all the activities observed. These data demonstrate a new procoagulant component produced from dual stimulation of platelets with thrombin and collagen. COAT-FV platelets may explain the unique role of alpha-granule FV and the hemostatic effectiveness of young platelets. (Blood. 2000;95:1694-1702)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688826

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  55 in total

1.  Properties of procoagulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase.

Authors:  Ammon M Fager; Jeremy P Wood; Beth A Bouchard; Ping Feng; Paula B Tracy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

2.  Procoagulant platelets form an α-granule protein-covered "cap" on their surface that promotes their attachment to aggregates.

Authors:  Anastasia A Abaeva; Matthias Canault; Yana N Kotova; Sergey I Obydennyy; Alena O Yakimenko; Nadezhda A Podoplelova; Vladimir N Kolyadko; Herve Chambost; Aleksei V Mazurov; Fazoil I Ataullakhanov; Alan T Nurden; Marie-Christine Alessi; Mikhail A Panteleev
Journal:  J Biol Chem       Date:  2013-08-30       Impact factor: 5.157

3.  Coated-platelets correlate with disease progression in Alzheimer disease.

Authors:  Calin I Prodan; E D Ross; A S Vincent; G L Dale
Journal:  J Neurol       Date:  2007-03-22       Impact factor: 4.849

4.  Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4.

Authors:  Fabrizio Semeraro; Concetta T Ammollo; James H Morrissey; George L Dale; Paul Friese; Naomi L Esmon; Charles T Esmon
Journal:  Blood       Date:  2011-06-14       Impact factor: 22.113

5.  Higher coated-platelet levels are associated with stroke recurrence following nonlacunar brain infarction.

Authors:  Calin I Prodan; Julie A Stoner; Linda D Cowan; George L Dale
Journal:  J Cereb Blood Flow Metab       Date:  2012-11-14       Impact factor: 6.200

6.  Inner Mitochondrial Membrane Disruption Links Apoptotic and Agonist-Initiated Phosphatidylserine Externalization in Platelets.

Authors:  Hyo-Jung Choo; Andaleb Kholmukhamedov; ChengZing Zhou; Shawn Jobe
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-06-29       Impact factor: 8.311

7.  Mitochondrially mediated integrin αIIbβ3 protein inactivation limits thrombus growth.

Authors:  Fang Liu; Graciela Gamez; David R Myers; Wayne Clemmons; Wilbur A Lam; Shawn M Jobe
Journal:  J Biol Chem       Date:  2013-09-06       Impact factor: 5.157

8.  Prospective evaluation of protein C and factor VIII in prediction of cancer-associated thrombosis.

Authors:  A J Tafur; G Dale; M Cherry; J D Wren; A S Mansfield; P Comp; S Rathbun; J A Stoner
Journal:  Thromb Res       Date:  2015-10-08       Impact factor: 3.944

9.  Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis.

Authors:  Shawn M Jobe; Katina M Wilson; Lorie Leo; Alejandro Raimondi; Jeffery D Molkentin; Steven R Lentz; Jorge Di Paola
Journal:  Blood       Date:  2007-11-07       Impact factor: 22.113

10.  Role of FcRgamma and factor XIIIA in coated platelet formation.

Authors:  Shawn M Jobe; Lorie Leo; Joshua S Eastvold; Gerhard Dickneite; Timothy L Ratliff; Steven R Lentz; Jorge Di Paola
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.